Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v3-EN
Language French English
Date Updated 2023-03-06 2023-02-06
Drug Identification Number 02237514 02237514
Brand name CIPRO ORAL SUSPENSION CIPRO ORAL SUSPENSION
Common or Proper name Ciprofloxacin Suspension Ciprofloxacin Suspension
Company Name BAYER INC BAYER INC
Ingredients CIPROFLOXACIN CIPROFLOXACIN
Strength(s) 500MG 500MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 mL 100 mL
ATC code J01MA J01MA
ATC description QUINOLONE ANTIBACTERIALS QUINOLONE ANTIBACTERIALS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2023-03-06 2023-02-17
Actual start date
Estimated end date 2023-03-10 2023-02-22
Actual end date 2023-03-03
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments Supply Constraints Supply Constraints
Health Canada comments